Icenticaftor, a Novel Treatment for Chronic Obstructive Pulmonary Disease, Needs Further Verification of Its Effectiveness

Am J Respir Crit Care Med. 2023 Nov 15;208(10):1140-1141. doi: 10.1164/rccm.202307-1268LE.

Authors

Qiming Gan¹, Kai Yang¹, Yanjuan Wu¹, Jingcun Wang¹, Haojie Zhang¹, Nuofu Zhang¹, Kang Wu¹

Affiliation

¹ State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, National Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.

No abstract available

Publication types

Letter

MeSH terms

Humans
Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

icenticaftor

Grants and funding

8210010336/Young Scientist Fund of National Natural Science Foundation of China/United States